PharmCube launches MCP for pharma

Model Context Protocol is a standard way to plug an artificial intelligence system into outside data, and PharmCube says it has now built that connector for pharmaceutical research workflows. (modelcontextprotocol.io) (anthropic.com) PharmCube said its new system uses Model Context Protocol, or MCP, to connect an agentic artificial intelligence tool to pharmaceutical databases so users can evaluate drug targets and companies with cited source material instead of relying on a model’s memory alone. (anthropic.com) (x.com) The company already sells data products built around the drug life cycle, including PharmaGO, a one-stop drug data warehouse, and NextBiopharm, a global new-drug database with fields for target, disease, clinical trials, patents, papers, deals and sales. (global.pharmcube.com 1) (global.pharmcube.com 2) (global.pharmcube.com 3) In plain terms, MCP works like a universal port for artificial intelligence tools: one standard connection can link a model to databases, search tools and workflows that would otherwise require separate custom integrations. (modelcontextprotocol.io) (anthropic.com) That matters in drug research because target reviews and company screens depend on current facts from many systems at once, including trial records, approval histories, patents, transactions and sales data. PharmCube says its own products are designed around those full-life-cycle decision points. (global.pharmcube.com 1) (global.pharmcube.com 2) (global.pharmcube.com 3) PharmCube says it works with more than 1,000 pharmaceutical companies and investment institutions, and says its databases cover the full span from research and development through registration, approval, market access and sales. (global.pharmcube.com) (pharmcube.com) Its PharmaGO product says it links 14 databases through one search interface and updates industry data at minute-level frequency, while relying on standardized cleaning, machine learning and human expert review. (global.pharmcube.com) Its NextBiopharm product says users can search tens of thousands of drug programs worldwide by drug name, target, disease and research institution, then pull in clinical results, merger-and-acquisition activity, patents, papers, news and sales. (global.pharmcube.com) The pitch behind the new launch is straightforward: if the model can pull from named pharmaceutical data sources at query time, the answer can be checked against those records instead of treated as a black box. MCP’s backers describe the protocol as a way to give models more relevant responses by connecting them directly to where data lives. (x.com) (anthropic.com) PharmCube’s announcement puts a pharmaceutical wrapper around a broader shift in artificial intelligence software, where vendors are moving from general chatbots toward tools that can retrieve, cite and act on domain-specific data. (anthropic.com) (modelcontextprotocol.io)